Global Insulin Pumps Market Report 2021-2030: Insulet, Medtronic, and Tandem Diabetes Care are the Major Stakeholders - Focus Report Store

According to Focus Report Store, the global insulin pump market [https://www.focusreports.store/report/insulin-pump-market] is growing at a CAGR of 9.10% during 2024-2030.

Looking for More Information? Click: https://www.focusreports.store/report/insulin-pump-market

Report Scope:

Market Size (2030): USD 7.27 Billion

Market Size (2024): USD 4.31 Billion

CAGR (2024-2030): 9.10%

Historic Year: 2021-2023

Base Year: 2024

Forecast Year: 2025-2030

Largest Region (2024): North America

Fastest-Growing Region: Asia Pacific

Segments By: Product Type, Insulin Pump, Indication Type, End-Users, And Geography

Geographic Analysis: North America, Europe, APAC, Latin America, And The Middle East & Africa

Market Overview

The insulin pumps market is experiencing significant growth, driven by the rising prevalence of diabetes, rapid advancements in medical technology, and a growing demand for precise and convenient diabetes management solutions. This upward trend is further supported by the increasing incidence of diabetes-particularly type 1-and the expanding adoption of advanced insulin delivery technologies.

A key factor contributing to this growth is the global surge in diabetes cases. Today, more than 589 million adults between the ages of 20 and 79 are living with diabetes, accounting for 1 in every 10 individuals. According to the International Diabetes Federation (IDF), this number is expected to reach 853 million by 2050. The majority of these individuals-approximately 3 in 4 reside in low- and middle-income countries. Diabetes continues to pose one of the most pressing public health challenges worldwide, contributing to around 6.7 million deaths in 2021 alone, which equates to one death every five seconds.

Transforming Diabetes Care: Rising Adoption of Automated Insulin Delivery (AID) Systems

The rising adoption of Automated Insulin Delivery (AID) systems marks a transformative shift in the global insulin pump market, driven by continuous technological innovation and proactive industry efforts. These advanced systems integrate continuous glucose monitors (CGMs) with insulin pumps to create a closed-loop mechanism that enables real-time blood glucose monitoring and automated insulin delivery. This integration not only simplifies diabetes management but also significantly improves patient outcomes. Clinical evidence highlights the benefits of AID systems, including a 10% average increase in time-in-range, reduced risk of diabetic ketoacidosis-related hospitalizations, and fewer instances of hypoglycemia. As healthcare providers and patients increasingly recognize the value of these systems, leading industry players are accelerating their adoption through product innovation and strategic initiatives.

Notable examples include Insulet's launch of the Omnipod 5 and Medtronic's release of the MiniMed 780G, both of which have driven substantial growth in their respective diabetes care portfolios. The growing prominence of AID systems signals a new era of personalized, tech-enabled diabetes care poised to reshape treatment standards globally.

Technological Advances in Insulin Pumps Driving Market Growth

Technological advancements are reshaping the insulin pump market, with innovations like Bluetooth-enabled devices and smartphone-controlled systems enhancing diabetes management. These features enable real-time communication between insulin pumps, continuous glucose monitors (CGMs), and smartphones, allowing users to monitor and adjust insulin delivery with ease. For instance, Insulet's Omnipod DASH and Tandem's t:slim X2 with Dexcom G6 CGM offer seamless integration and predictive tools that help prevent hypoglycemia. Additionally, systems like Medtronic's MiniMed 780G represent a major step forward, using advanced algorithms to automatically adjust insulin every five minutes, bringing diabetes care closer to the functionality of a natural pancreas. These advancements mark a significant step forward in delivering personalized, responsive, and effective diabetes management solutions.

Recent Development

*
In 2025, the Tandem Diabetes Care received US FDA clearance & commercial launch for its next-generation automated insulin delivery (AID) algorithm, Control-IQ+ technology (Control-IQ+), for use by people with type 2 diabetes ages 18 and older.

*
In 2022, Medtronic announced the reimbursement for its MiniMed 770 G insulin pump system covered by the US Medicare and available with reimbursement in some countries. The primary reimbursement has been expanded in North & South American countries.

North America Leads, APAC Shows Fastest Growth

North America dominates and holds the largest global insulin pump market share of over 38%. North America stands as the dominant region in the global insulin pump market, driven by advanced healthcare infrastructure, high diabetes prevalence, and widespread adoption of medical technologies. The US and Canada have been at the forefront of insulin pump innovation, usage, and regulatory advancements. North America, particularly the US, stands as the most mature market for insulin pumps. The region benefits from a well-established healthcare system, high diabetes prevalence, robust insurance coverage, and the presence of leading insulin pump manufacturers such as Medtronic and Tandem Diabetes Care. In addition, the presence of market players and greater access to the insulin pump solution with higher economic stability give a boost to the market growth. Medtronic, Insulet, and Tandem Diabetes Care are the three major companies which has significant market penetration in the region.

The APAC region is expected to grow at the fastest CAGR of 10.84% during the forecast period. The APAC region presents a significant burden of diabetes. According to the IDF, countries like China and India have some of the highest numbers of people living with diabetes globally. Rising urbanization, sedentary lifestyles, and dietary changes have contributed to a surge in both Type 1 and Type 2 diabetes, particularly in urban and middle-income populations. The regulatory landscape in APAC is evolving, with a growing emphasis on patient safety and medical device efficacy. Countries such as Japan, South Korea, and Australia have well-established regulatory bodies that closely evaluate insulin pump products before approval.

Key Vendors

*
Insulet

*
Medtronic

*
Tandem Diabetes Care

Other Prominent Vendors

*
CeQur Simplicity

*
Debiotech SA

*
EOFLOW

*
F. Hoffmann-La Roche

*
IA Collaborative Holdings

*
Jiangsu Delfu medical device

*
LenoMed Medical

*
MannKind

*
Medtrum Technologies

*
Medzer

*
MicroPort Scientific

*
MicroTech Medical

*
Novo Nordisk

*
Shanghai Umitai Medical Technology

*
SOOIL Developments

*
Terumo

*
ViCentra B.V.

*
YPSOMED AG

*
Modular Medical

*
Beta Bionics

Market Segmentation & Forecasts

Product

*
Insulin Pump

*
Consumables

Insulin Pump

*
Tethered Pump

*
Patch Pump

Indication

*
Type 1 Diabetes

*
Type 2 Diabetes

End-Users

*
Hospitals

*
Home Healthcare Settings

*
Others

Geography

North America

*
US

*
Canada

Europe

*
Germany

*
France

*
UK

*
Italy

*
Spain

*
Russia

*
Netherlands

APAC

*
China

*
Japan

*
India

*
South Korea

*
Australia

Latin America

*
Brazil

*
Mexico

*
Argentina

*
Columbia

Middle East & Africa

*
Turkey

*
Saudi Arabia

*
South Africa

In a nutshell, the Arizton Advisory & Intelligence market research report provides valuable market insights for industry stakeholders, investors, researchers, consultants, and business strategists aiming to gain a thorough understanding of the global insulin pump market. Request for Free Sample to get a glance of the report now: https://www.focusreports.store/report/insulin-pump-market

Other Related Reports that Might be of Your Business Requirement

Global Blood Glucose Monitoring Devices Market - Focused Insights 2024-2029

https://www.focusreports.store/report/blood-glucose-monitoring-devices-market-focused-insights

Blood Culture Tests Market - Global Outlook & Forecast 2024-2029

https://www.focusreports.store/report/blood-glucose-monitoring-devices-market-focused-insights

What Key Findings Will Our Research Analysis Reveal?

How big is the global insulin pump market?

How are technological advancements impacting the market?

What is the growth rate of the global insulin pump market?

What is driving the growth of the global insulin pump market?

Are insulin pumps used for both Type 1 and Type 2 diabetes?

Who are the key players in the global insulin pump market?

Why Arizton?

100%Customer Satisfaction

24x7availability - we are always there when you need us

200+Fortune 500 Companies trust Arizton's report

80%of our reports are exclusive and first in the industry

100%more data and analysis

1500+reports published till date

Post-Purchase Benefit

*
1hr of free analyst discussion

*
10% off on customization

About Us:

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.

Media Contact
Company Name: Arizton Advisory & Intelligence
Contact Person: Jessica
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=global-insulin-pumps-market-report-20212030-insulet-medtronic-and-tandem-diabetes-care-are-the-major-stakeholders-focus-report-store]
Phone: +1 3122332770
Country: United States
Website: https://www.focusreports.store/report/insulin-pump-market

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.